141 results
8-K
NRBO
NeuroBo Pharmaceuticals Inc
7 Jun 24
Departure of Directors or Certain Officers
4:06pm
Incentive Plan (the “2022 Equity Incentive Plan”). On June 7, 2024, at the Annual Meeting (as defined below), the stockholders of the Company approved … the First Amendment to 2022 EIP.
Pursuant to the terms and conditions of the First Amendment to 2022 EIP, the 2022 Equity Incentive Plan was amended
8-K
EX-10.1
NRBO
NeuroBo Pharmaceuticals Inc
7 Jun 24
Departure of Directors or Certain Officers
4:06pm
Exhibit 10.1
FIRST AMENDMENT
TO THE NEUROBO PHARMACEUTICALS, INC.
2022 EQUITY INCENTIVE PLAN
This First Amendment to the NeuroBo Pharmaceuticals … , Inc. 2022 Equity Incentive Plan (this “First Amendment”) is made and adopted by NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the “Company
8-K
EX-99.1
nbuwlw476rk
16 Apr 24
Other Events
4:30pm
8-K
EX-10.1
jre6cf2h1qk4rzngut
4 Mar 24
NeuroBo Pharmaceuticals Appoints Seasoned Life Science Executive
7:30am
8-K
qg2cmpndzakq
4 Mar 24
NeuroBo Pharmaceuticals Appoints Seasoned Life Science Executive
7:30am
8-K
EX-99.1
72nium40z2lvb
14 Feb 24
Other Events
8:52am
8-K
eb5doswjn028zg
19 Dec 23
NeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock Split
9:03am
8-K
EX-99.1
lpi2d 88moitmq9uad
7 Dec 23
Regulation FD Disclosure
9:20am
8-K
elcfltf1bnf4bffd
6 Nov 23
Departure of Directors or Certain Officers
8:20am
8-K
EX-99.1
yf9knpjgay06 cik
22 Sep 23
Regulation FD Disclosure
8:03am
8-K
dlnh6n2x2h543d8x
14 Aug 23
Neurobo Pharmaceuticals Appoints Hyung Heon Kim
8:18am
8-K
EX-10.1
vb8hr7y0tiu0u08eag
14 Aug 23
Neurobo Pharmaceuticals Appoints Hyung Heon Kim
8:18am